arrow_back Back to App

Major Funding Boost for Liver Disease Research, Prevention, and Awareness.

This law allocates federal funding to expand research, prevention, and public awareness campaigns targeting liver diseases, including cancer and viral hepatitis (B/C). It aims to improve early detection, screening access, and treatment options, particularly for high-risk and underserved communities. The legislation also elevates the status of liver disease research within the National Institutes of Health (NIH).
Key points
Authorizes $145 million annually (FY 2025-2029) for grants supporting liver disease research, prevention programs (screenings, vaccinations), and targeted awareness initiatives.
Renames and restructures the National Institute of Diabetes and Digestive and Kidney Diseases to include Liver Diseases, establishing a dedicated Division of Liver Diseases.
Funds community-based programs focused on providing culturally appropriate information and preventative care to populations disproportionately affected by liver cancer.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_8601
Sponsor: Rep. Velázquez, Nydia M. [D-NY-7]
Process start date: 2024-06-03
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Liver Illness Visibility, Education, and Research Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_8601.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-06-03.

What are the main provisions?

Key points include:

  • Authorizes $145 million annually (FY 2025-2029) for grants supporting liver disease research, prevention programs (screenings, vaccinations), and targeted awareness initiatives.
  • Renames and restructures the National Institute of Diabetes and Digestive and Kidney Diseases to include Liver Diseases, establishing a dedicated Division of Liver Diseases.
  • Funds community-based programs focused on providing culturally appropriate information and preventative care to populations disproportionately affected by liver cancer.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Velázquez, Nydia M. [D-NY-7].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

CATEGORIES

Health